A clinical formulation indicated for Erectile Dysfunction. This treatment aids in the management of physical responsiveness by enhancing blood flow during periods of stimulation.
A long-acting PDE5 inhibitor designed to support erectile function and intended to alleviate urinary symptoms of BPH to manage male health for 36 hours.
Mechanism of Action
It inhibits the PDE5 enzyme, relaxing smooth muscles and increasing blood flow to the penis and prostate area during sexual stimulation.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
Up to 36 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Low blood pressure, Allergy to tadalafil
Information for Tadalista is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
